by Team Archbow | Dec 17 | Distribution, HUBs, Market Access, Patient Access, Specialty Pharmacy, Technology
INSIGHTS Home 9 Tag: Biotech • Navigating the Evolving Pharma Landscape: A Year in Review Archbow Consulting’s insights served as a valuable resource for navigating a year of evolving trends. Navigating the Evolving Pharma Landscape...
by Team Archbow | Nov 21 | HUBs, Market Access, Patient Access, Strategy
INSIGHTS Home 9 Tag: Biotech • Revolutionizing Patient Care: The Top 5 Benefits of Investing in Innovation New whitepaper from Archbow Consulting is available for download now. Top Five Reasons Why an Innovation Investment in Patient...
by Shannon Hybner | Oct 23 | All
INSIGHTS Home 9 Tag: Wholesale r • FDA Extends Compliance Deadline for Updated DSCSA Requirements The U.S. FDA recently announced a revised timeline for compliance with specific updated Drug Supply Chain Security Act (DSCSA) requirements....
by Team Archbow | Oct 22 | Industry News, Market Access, Patient Access
INSIGHTS Home 9 Author archive for Team Archbow Team Archbow • Are Direct-to-Patient Access Models the Future of Pharma? Archbow discusses the growing potential to sell directly to patients via a cash model. Are Direct-to-Patient Access...
by Team Archbow | Oct 17 | All, Market Access, Specialty Pharmacy, Strategy
INSIGHTS Home 9 Author archive for Team Archbow Team Archbow • Key Takeaways from NASP 2024 The 2024 NASP conference provided valuable insights into the future of specialty pharmacy. Key Takeaways from NASP 2024 The 2024 National...
